336 related articles for article (PubMed ID: 21940679)
1. The NF-κB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis.
Chen G; Hardy K; Pagler E; Ma L; Lee S; Gerondakis S; Daley S; Shannon MF
J Immunol; 2011 Nov; 187(9):4483-91. PubMed ID: 21940679
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
[TBL] [Abstract][Full Text] [Related]
3. 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.
Kim YH; Choi BK; Shin SM; Kim CH; Oh HS; Park SH; Lee DG; Lee MJ; Kim KH; Vinay DS; Kwon BS
J Immunol; 2011 Aug; 187(3):1120-8. PubMed ID: 21715692
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.
Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC
J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607
[TBL] [Abstract][Full Text] [Related]
5. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
7. c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.
Reinhard K; Huber M; Wostl C; Hellhund A; Toboldt A; Abass E; Casper B; Joeris T; Herr C; Bals R; Steinhoff U; Lohoff M; Visekruna A
Eur J Immunol; 2011 May; 41(5):1388-98. PubMed ID: 21469108
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine.
Qin X; Guo BT; Wan B; Fang L; Lu L; Wu L; Zang YQ; Zhang JZ
J Immunol; 2010 Aug; 185(3):1855-63. PubMed ID: 20622114
[TBL] [Abstract][Full Text] [Related]
9. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
[TBL] [Abstract][Full Text] [Related]
10. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
[TBL] [Abstract][Full Text] [Related]
11. PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation.
Haylock-Jacobs S; Comerford I; Bunting M; Kara E; Townley S; Klingler-Hoffmann M; Vanhaesebroeck B; Puri KD; McColl SR
J Autoimmun; 2011 May; 36(3-4):278-87. PubMed ID: 21396797
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells.
Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y
J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042
[TBL] [Abstract][Full Text] [Related]
13. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
Oh SJ; Chung DH
J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
[TBL] [Abstract][Full Text] [Related]
14. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
15. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
[TBL] [Abstract][Full Text] [Related]
16. Salmon proteoglycan suppresses progression of mouse experimental autoimmune encephalomyelitis via regulation of Th17 and Foxp3(+) regulatory T cells.
Sashinami H; Asano K; Yoshimura S; Mori F; Wakabayashi K; Nakane A
Life Sci; 2012 Dec; 91(25-26):1263-9. PubMed ID: 23069584
[TBL] [Abstract][Full Text] [Related]
17. T cell-specific BLIMP-1 deficiency exacerbates experimental autoimmune encephalomyelitis in nonobese diabetic mice by increasing Th1 and Th17 cells.
Lin MH; Yeh LT; Chen SJ; Chiou HY; Chu CC; Yen LB; Lin KI; Chang DM; Sytwu HK
Clin Immunol; 2014 Apr; 151(2):101-13. PubMed ID: 24568746
[TBL] [Abstract][Full Text] [Related]
18. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
[TBL] [Abstract][Full Text] [Related]
20. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis.
Marta M; Andersson A; Isaksson M; Kämpe O; Lobell A
Eur J Immunol; 2008 Feb; 38(2):565-75. PubMed ID: 18203139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
